Compositions and methods for phosphoramidite and oligonucleotide synthesis

Inventors

Butler, David Charles Donnell • Marappan, Subramanian • Paik, Ik-Hyeon

Assignees

Wave Life Sciences Pte Ltd

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-11407775-B2

Patent

Publication Date

2022-08-09

Expiration Date


Abstract

The present disclosure, among other things, provides technologies for preparing and purifying phosphoramidites for oligonucleotide synthesis.

Core Innovation

The disclosed innovation provides a method for purifying phosphoramidites using a purification medium contacted or pretreated with a hygroscopic solvent system containing acetonitrile or methanol. This treatment addresses irreversible adsorption and decomposition by removing water or reducing reactive sites on the purification medium. The disclosed phosphoramidites encompass structures of formula I incorporating cyclic chiral auxiliary features and nucleoside phosphoramidites with silicon-containing substituents, with specific treatment conditions being [procedural detail omitted for safety].

The disclosure also provides a method combining the formation of a phosphoramidite from a nucleoside and a chiral auxiliary with subsequent purification using the conditioned medium. The purification approach improves separation, recovery, yield, and purity, including for phosphoramidites bearing O6-unprotected guanine residues. These compounds and methods support oligonucleotide preparation and synthesis, providing improvements in performance and diastereoselectivity for chirally controlled oligonucleotides.

Claims Coverage

The two independent claims cover two inventive features directed to the purification and preparation of phosphoramidites.

Purification of a phosphoramidite

Independent claim 1 covers contacting a purification medium with a hygroscopic solvent system containing acetonitrile or methanol to purify a phosphoramidite of formula I having Ring A cyclic chiral auxiliary features and defined nucleobase substituents; [procedural detail omitted for safety].

Preparation and purification of a phosphoramidite

Independent claim 18 covers forming a phosphoramidite from a nucleoside and a chiral auxiliary, followed by purification using a purification medium contacted with a hygroscopic solvent system containing acetonitrile or methanol; [procedural detail omitted for safety].

The independent claims cover phosphoramidite purification using a treated medium and a preparation method combining phosphoramidite formation with purification.

Stated Advantages

Reduces irreversible adsorption and decomposition of phosphoramidites during purification, thereby improving separation.

Improves phosphoramidite recovery, yield, and purity, including for phosphoramidites bearing O6-unprotected guanine residues.

Provides improvements in diastereoselectivity, yield, and synthesis performance for chirally controlled oligonucleotides.

Documented Applications

Purification and preparation of phosphoramidites.

Preparation and synthesis of chirally controlled oligonucleotides.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.